Valeritas’ V-Go clinical trial evaluating delivery of insulin meets primary A1c endpoint
The DSMC concluded that the data collected was sufficient to support the conclusion that the study had successfully…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Aug 19
The DSMC concluded that the data collected was sufficient to support the conclusion that the study had successfully…
08 Aug 19
The shipments are part of the first phase of Nemaura Medical’s rollout program for SugarBEAT following its recent…
02 Aug 19
By integrating connected medical device components and glucose and insulin data, Bigfoot Biomedical aims to reduce burden of…
02 Aug 19
The AHN Center for Diabetes and Endocrine Health has established a transformational patient-centered diabetes care model to more…
18 Jul 19
Know Labs, a creator of innovative medical diagnostic solutions, announced significant progress in the development of its wearable…
Beta Bionics, a medical technology company has signed a signed collaboration and development agreement with ConvaTec, a leading…
Nemaura Medical is seeking approval from the US Food & Drug Administration (FDA) for its SugarBEAT continuous glucose…
Fresenius Medical Care North America (FMCNA), a provider of kidney care products and services, has announced a major…
09 Jul 19
Valeritas Holdings, a medical technology company and maker of the V-Go Wearable Insulin Delivery device, announced today positive…
05 Jul 19
Sernova, a clinical-stage regenerative medicine company, announced that its Cell Pouch transplanted with islet cells showed positive results…